Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1453 of 6351
-
Can the MenB vaccine protect kids with rheumatic conditions?
Vaccine Recruiting nowThe goal of this clinical trial is to evaluate the humoral immunogenicity of the meningococcal B vaccine (MenB-4C) in pediatric patients with autoimmune rheumatic diseases (ARDs), compared to age- and sex-matched non-immunosuppressed controls. The main questions it aims to answe…
Phase 4 • Sponsor: University of Sao Paulo General Hospital • Aim: Vaccine
Last updated Jun 27, 2026 12:10 UTC
-
New eye drops aim to heal damaged corneas
Symptom relief Recruiting nowObjective: To evaluate the safety of Lacripep 4 μM Ophthalmic Solution and its effect on the ocular surface, visual function, corneal sensitivity, and quality of life of subjects with Stage 1 NK.
Phase 2 • Sponsor: TearSolutions, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
New nerve block could replace needle in the back for spinal headaches
Symptom relief Recruiting nowPost-dural puncture headache (PDPH) is an iatrogenic complication following a dural puncture, which may occur after lumbar puncture, spinal or epidural anesthesia. These headaches are defined as positional headaches, which worsen in the upright position and improve in the supine …
Phase 3 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Online lifestyle program aims to cut breast cancer risk in High-Risk women
Prevention Recruiting nowBreast cancer remains the most common cancer among women and a major cause of death despite advances in screening and treatment. Current screening programs are not personalized and are experiencing declining participation. A promising strategy for breast cancer control would be t…
Sponsor: UNICANCER • Aim: Prevention
Last updated Jul 25, 2026 00:00 UTC
-
Simple skin test may spot Parkinson's risk years early
Knowledge-focused Recruiting nowBackground and Rationale Essential tremor (ET) affects over 6 million Americans and approximately 5% of adults over age 60. Patients with ET have a 10-20 times higher risk of developing Parkinson's disease (PD) compared to age-matched populations, with approximately 1% converting…
Sponsor: CND Life Sciences • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
Malaria vaccine booster trial aims to keep school kids protected
Vaccine OngoingThis trial is a double-blind, randomised, trial recruiting participants from the R21 phase IIb trial (VAC 076) which took place between May 2019 and July 2023 in Nanoro, Burkina Faso. Participants (n=30-40) who have previously received four doses of the 5µg R21/50µg Matrix-M mal…
Phase 2 • Sponsor: University of Oxford • Aim: Vaccine
Last updated Aug 26, 2026 00:00 UTC
-
New immune combo takes on tough pancreatic cancer
Disease control Recruiting nowThis is an open-label, single-arm clinical study designed to evaluate the safety and preliminary efficacy of Claudin18.2 Targeted Activated DC combined with CAR-T therapy in patients with Advanced Pancreatic Cancer. This combination therapy activates dendritic cells (DCs) to pre…
Early phase 1 • Sponsor: Hainan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Blood oxygen dips may reveal who stays on CPAP
Knowledge-focused Recruiting nowObstructive sleep apnea (OSA) is commonly assessed using the apnea-hypopnea index, although this measure does not fully reflect cardiovascular risk or the physiological impact of the disease. Emerging biomarkers, including sleep apnea-specific hypoxic burden, pulse wave amplitude…
Sponsor: Clinique du Millenaire • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
New drug SB-4826 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThe goal of this clinical trial is to learn what dose of the drug SB-4826 can be given safely in patients with solid tumors and non-Hodgkin lymphomas. This drug will be used alone in patients with solid tumors, and will be used alone or in combination with rituximab in patients w…
Phase 1/2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New Clot-Sucking device could limit heart attack damage
Disease control Recruiting nowThe aim of this study is to evaluate the impact of sustained thrombectomy with INDIGO ASPIRATION SYSTEM using CAT RX versus no thrombectomy during primary percutaneous coronary intervention (PPCI) on microvascular obstruction and infarct size, as measured by cardiovascular magnet…
Sponsor: Ceric Sàrl • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for rheumatoid arthritis sufferers: experimental drug ELV001 enters phase 2 trial
Disease control Recruiting nowThis is a Phase 2 randomized, double-blind, placebo-controlled study with a total duration of 32 weeks from Screening to End-of-Study (EOS) Visit. Approximately 180 participants are planned to be enrolled. The number of participants can be extended to maximally 220 to account for…
Phase 2 • Sponsor: Elevara Medicines Limited • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Choice of injectable opioid treatment may help former inmates stay on track
Disease control Recruiting nowThe goal of this pilot trial is to compare two branded extended-release buprenorphine (XR-B) formulations (Sublocade vs. Brixadi) to explore how they improve treatment retention after release from prison among incarcerated individuals with opioid use disorder (OUD) who are transi…
Phase 4 • Sponsor: Lifespan • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
AR goggles guide surgeons to leftover cancer cells in head and neck surgery
Knowledge-focused Recruiting nowHead and neck cancers have one of the highest recurrence rates among solid malignancies, and recurrence is strongly correlated with overall survival. Reducing recurrence rates depends, in part, on the surgeon's ability to accurately re-resect areas of positive or close margins du…
Early phase 1 • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Can a voice therapy program help turkish speakers with Parkinson's speak louder and clearer?
Symptom relief Recruiting nowParkinson's disease often causes speech and voice impairments, such as reduced vocal loudness and decreased speech intelligibility, which significantly impact the quality of life for patients and their families. The Lee Silverman Voice Therapy-LOUD (LSVT-LOUD) is a specialized, e…
Sponsor: Atlas University • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
New hope for advanced cancer: experimental drug CR-001 enters human trials
Disease control Recruiting nowThe purpose of this study is to determine the safety and tolerability of monotherapy CR-001 and identify the maximum tolerated dose (MTD), and/or optimal biologic dose and Recommended Phase 2 Dose(s) (RP2D) in participants with locally advanced or metastatic solid tumors.
Phase 1/2 • Sponsor: Crescent Biopharma, Inc. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Arm rehab showdown: which therapy boosts hand function in kids with CP?
Disease control Recruiting nowChildren with spastic diplegic cerebral palsy often experience upper extremity impairments, including reduced coordination, muscle control, and functional hand use, which limit independence in daily activities. Proprioceptive Neuromuscular Facilitation (PNF) and Task-Oriented Tra…
Sponsor: Ibadat International University, Islamabad • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New pancreatic cyst test could prevent cancer by guiding treatment
Diagnosis Recruiting nowThe purpose of this research is to learn if the PanCystPro assay can help doctors in making decisions about treatment and monitoring of pancreatic cysts. The PanCystPro test measures glucose, carcinoembryonic antigen (CEA), and gastricsin biomarkers on fluid obtained from a pancr…
Sponsor: Amplified Sciences Inc • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
New psoriasis pill shows promise in major trial
Disease control Recruiting nowAn open label study to investigate the safety and efficacy of ponesimod in participants with moderate-to-severe chronic plaque psoriasis
Phase 3 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New sensor aims to cut hospital visits after heart valve fix
Disease control Recruiting nowTricuspid regurgitation (TR) is a severe and highly prevalent disease that leads to right-sided heart failure. The severity of TR is associated with increasing morbidity and mortality. While severe TR and right-sided heart failure have an impact on the quality of life and prognos…
Sponsor: LMU Klinikum • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New hope for rare blood cancers: experimental drug ELA026 enters human testing
Disease control Recruiting nowThis is a Phase 1, two-part, multicenter study to evaluate ELA026 in participants ≥18 years old with relapsed/refractory TCM following any line of prior therapy who are eligible for investigational treatments.
Phase 1 • Sponsor: Electra Therapeutics Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC